10.22.15
Intertek has expanded its GLP Bioanalytical Centre of Excellence in San Diego, CA. The capacity and new technology expansion includes 46,000-sq.-ft. of labs, offices and sample storage for preclinical and clinical development of small molecule and biologic drugs. The investment in new bioanalytical technologies aims to expedite delivery of bioanalysis results for global clients.
The facility offers new technologies such as flow cytometry, which provides analysis of cells to help understand the mechanism of action of drugs and to help facilitate evaluation of drug stability and potency. Flow cytometry also provides a platform for assessing cell based neutralizing antibody activity in clinical trials, which is important in assessing potential adverse immunological effects.
Luminex technology will build on current high throughput and multiplexing capabilities to allow customized measurement of up to 100 analytes simultaneously using very small volumes of sample. Also, new liquid chromatography- mass spectrometry (LC-MS) instruments improve sensitivity and mass range for analysis of protein therapeutics.
Mark Hammond, Intertek Pharmaceutical Services business leader, said, “Our expanded GLP Bioanalytical Centre of Excellence in San Diego and new technologies provide a broader range of bioanalytical, biomarker, and cell-based capabilities services to meet our clients’ needs in preclinical and clinical bioanalysis, helping them to understand the safety, efficacy and mechanism of action of their small and large molecule drugs in development.”
The facility offers new technologies such as flow cytometry, which provides analysis of cells to help understand the mechanism of action of drugs and to help facilitate evaluation of drug stability and potency. Flow cytometry also provides a platform for assessing cell based neutralizing antibody activity in clinical trials, which is important in assessing potential adverse immunological effects.
Luminex technology will build on current high throughput and multiplexing capabilities to allow customized measurement of up to 100 analytes simultaneously using very small volumes of sample. Also, new liquid chromatography- mass spectrometry (LC-MS) instruments improve sensitivity and mass range for analysis of protein therapeutics.
Mark Hammond, Intertek Pharmaceutical Services business leader, said, “Our expanded GLP Bioanalytical Centre of Excellence in San Diego and new technologies provide a broader range of bioanalytical, biomarker, and cell-based capabilities services to meet our clients’ needs in preclinical and clinical bioanalysis, helping them to understand the safety, efficacy and mechanism of action of their small and large molecule drugs in development.”